Nasir Hussain is an associate in Winston & Strawn’s internationally recognized litigation practice. Nas has experience representing clients at all stages of litigation, with an emphasis on antitrust matters (both litigation and merger reviews), securities-related matters (litigation and government investigations), and other complex commercial disputes. Nas has extensive experience in litigation matters before both state courts and federal courts throughout the United States, and also represents clients in investigations by government agencies, including the U.S. Department of Justice, the U.S. Federal Trade Commission, and the U.S. Securities and Exchange Commission. He has also worked on merger control filings and reviews by several foreign antitrust authorities in multi-billion-dollar global transactions. Nas is a member of Winston & Strawn’s Health Care and Life Sciences Group and regularly serves health care clients in litigation and with regulatory matters, including counseling clients on matters involving state and federal controlled substances regulations. Nas also has considerable experience working with clients in a broad range of other industries, including manufacturing and financial services.